Get started
Author

Vít Campr

Observed names: Campr V, Campr, Vít, V Campr, V. CAMPR, V. Campr, Vit Campr, Vít CAMPR
Observed institutions: Charles University, Institute of Haematology and Blood Transfusion, University Hospital in Motol, Na Homolce Hospital, University Hospital Kralovske Vinohrady, General University Hospital in Prague
ORCID: 0009-0009-1542-546X
Observed ORCID: 0009-0009-1542-546X
OpenAlex ID: A5085568642
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
2021 · Sushree S. Sahoo, Victor B. Pastor, et al. · Nature Medicine · 170
PDF
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
2014 · Sven Kracker, James Curtis, et al. · Journal of Allergy and Clinical Immunology · 109
Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria
2012 · Irith Baumann, Monika Führer, et al. · Histopathology · 80
Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome
2016 · M. Novakova, M.  aliova, et al. · Haematologica · 73
Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood
2013 · A. Yoshimi, M. M. van den Heuvel-Eibrink, et al. · Haematologica · 39
PDF
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome
2023 · Adriana A. de Jesus, Guibin Chen, et al. · Nature Communications · 37
PDF
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent
2014 · Vít Procházka, Robert Pytlík, et al. · PLoS ONE · 36
PDF
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients
2019 · Andrea Janikova, Renata Chloupkova, et al. · Annals of Hematology · 35
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
2014 · Andrea Janikova, Zbynek Bortlicek, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry
2016 · Heidi Mocikova, Robert Pytlik, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 30
The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab
2012 · K. BENESOVA, K. FORSTEROVA, et al. · Neoplasma · 30
PDF
Thrombosis in thrombocythemic Ph‐ myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide
2015 · Jiří Schwarz, Petra Ovesná, et al. · European Journal Of Haematology · 25
PDF
Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization
2003 · Roman Kodet, Marcela Mrhalová, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 25
Multiple granular cell tumour
2004 · G Janoušková, V Campr, et al. · Journal of the European Academy of Dermatology and Venereology · 24
Alternating R‐CHOP and R ‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma
2017 · Pavel Klener, Eva Fronkova, et al. · Hematological Oncology · 22
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database
2018 · Andrea Janikova, Zbynek Bortlicek, et al. · Annals of Hematology · 16
Analysis of Risk Factors: The Rationale of the Guidelines of the Czech Hematological Society for Diagnosis and Treatment of Chronic Myeloproliferative Disorders with Thrombocythemia
2006 · Jiří Schwarz, Robert Pytlík, et al. · Seminars in Thrombosis and Hemostasis · 16
Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
2022 · Heidi Mocikova, Robert Pytlík, et al. · Frontiers in Oncology · 15
PDF
Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
2006 · J Schwarz, D Mikulenková, et al. · PubMed · 15
Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
2018 · Pavel Klener, David Salek, et al. · American Journal of Hematology · 11
PDF
Clonal Mutational Landscape of Childhood Myelodysplastic Syndromes
2015 · Emilia J Kozyra, Shinsuke Hirabayashi, et al. · Blood · 10
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database
2015 · Andrea Janikova, Zbynek Bortlicek, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
[Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
2011 · J Schwarz, M Penka, et al. · PubMed · 10
G‐CSF stimulated islands of haematopoiesis mimicking disseminated malignancy on PET‐CT and MRI scans in a patient with hypoplastic marrow disorder
2005 · Michal Kouba, Jacqueline Maaloufova, et al. · British Journal of Haematology · 9
Staging and Treatment Response Evaluation in Malignant Lymphomas – Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)
2016 · Alice Sýkorová, Robert Pytlík, et al. · Klinicka onkologie · 8
PDF
Works count: 120
Citation count: 1,022
H-index: 16
I10-index: 23
Year
Topic
Type